ClinicalTrials.gg
Not yet recruitingNCT07523373Updated Apr 13, 2026

Facial Nerve Monitoring During Parotid and Facial Surgery Using a Non-Invasive Patch

An interventional study of Non-invasive facial nerve monitoring patch in Parotid Gland Tumor and Facial and Neck Rhytides, sponsored by Sheba Medical Center. Not yet recruiting. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2026-04-13.

Sponsored by Sheba Medical Center · Not applicable, Interventional, and Device feasibility

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
18 Years to 99 Years
Sex
All
01

Study summary

The goal of this study is to test if a non-invasive patch can safely monitor facial nerve activity in adults during parotid or facial surgery. Monitoring the facial nerve during these surgeries helps lower the risk of nerve injury and possible functional and aesthetic damage. Current methods use small needles and require careful placement, which can be difficult and may affect how well they work.

The aims to answer the following questions:

  • Can the patch provide similar results to the standard monitoring method?
  • Is the patch safe and easy to use during surgery?

The research team will compare the readings from the patch with those from the standard method used during surgery.

Participants will:

  • Undergo their planned surgery as usual
  • Have a patch placed on the face before the surgery
  • Have both the standard method and the patch monitor the facial nerve during surgery
  • Have the data extracted from the monitoring tools and analyzed without personal identifying information.

All the decisions during surgery will be based only on the standard method.

02

Conditions studied

  • Parotid Gland Tumor
  • Facial and Neck Rhytides

Browse trials for

03

In context

Parotid Neoplasms

27 studies on the registry are indexed under Parotid Neoplasms; 7 are open to participants now.

This study's planned enrollment of 20 is below the median of 55 across 18 interventional studies indexed under Parotid Neoplasms.

Browse Parotid Neoplasms studies →

Lead sponsor

Sheba Medical Center is the lead sponsor of 678 studies on the registry; 63 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 to 99 years
  • Hebrew speakers
  • Ability to understand the study requirements and provide
  • Ability to cooperate with the research team throughout the study procedures

Exclusion criteria

Exclusion Criteria:

  • Current or past comorbidity affecting facial nerve function
  • Previous injection of botulinum toxin to the face
  • Skin conditions that may interfere with the placement or function of the patch, according to the manufacturer's guidelines
  • Known allergy to any component of the dry electrode patch
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Investigational drug or device

A drug or device being studied in a clinical trial.

It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.

05

Study design

Phase
Not applicable
Primary purpose
Device feasibility
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Dual Facial Nerve Monitoring

    Participants will undergo intraoperative facial nerve monitoring using the standard monitoring method along with a non-invasive patch applied to the face. Both methods will be used during the same surgery for all participants, and clinical decisions will be based solely on the standard monitoring method.

    Device: Non-invasive facial nerve monitoring patch

Interventions

  • DeviceNon-invasive facial nerve monitoring patch

    A non-invasive surface electrode patch applied to the face to continuously monitor facial nerve activity during surgery. The patch uses dry electrodes to detect electrical signals associated with nerve stimulation and muscle activity. Data are recorded throughout the procedure for analysis. The patch operates in parallel with the standard monitoring method and does not influence clinical decision making.

06

What researchers measure

Primary outcomes

  1. Agreement between the patch and the standard monitoring tool in detecting facial nerve activity

    Agreement between the non-invasive patch and the standard monitoring method in detecting facial nerve activity during surgery. Agreement evaluation will be based on concordance in detection and temporal correlation of nerve responses recorded by both methods during intraoperative stimulation.

    Time frame: During surgery

Secondary outcomes

  1. Safety of non-invasive patch use

    Evaluation of device-related adverse effects associated with the use of the non-invasive facial nerve monitoring patch during surgery, including skin reactions or other local adverse effects.

    Time frame: During surgery

  2. Ease of Use of Non-Invasive Patch-Based Facial Nerve Monitoring

    Subjective assessment regarding the usability and integration of the patch during surgery

    Time frame: During surgery

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for May 2026; primary completion for Feb 2027, 9 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 4, 2026
First posted
Apr 13, 2026
StartEst.
May 1, 2026
Primary completionEst.
Feb 18, 2027
CompletionEst.
Feb 18, 2028
Last update
Apr 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07523373
Responsible party
Dr. Mor Peri Bitterman (physician, Sheba Medical Center) — Principal investigator
First posted
Apr 13, 2026
Start date
May 1, 2026 (estimated)
Primary completion
Feb 18, 2027 (estimated)
Completion
Feb 18, 2028 (estimated)
Last update
Apr 13, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion